Shinkichi Takamori

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Brain Metastases

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shinkichi Takamori, Junjia Zhu, Asato Hashinokuchi, Takefumi Komiya
The Clinical Role of Adjuvant Chemotherapy after Sublobar Resection for Non-Small-Cell Lung Cancer ≤ 20 mm with Lymph Node Metastases: A Propensity-Matched Analysis of the National Cancer Database. Cancers 16 (12) (2024)
Shinkichi Takamori, Junjia Zhu, Asato Hashinokuchi, Takefumi Komiya
The Clinical Role of Adjuvant Chemotherapy after Sublobar Resection for Non-Small-Cell Lung Cancer ≤ 20 mm with Lymph Node Metastases: A Propensity-Matched Analysis of the National Cancer Database. Cancers 16 (12) (2024)
Tomoyoshi Takenaka, Tokujiro Yano, Koji Yamazaki, Tatsuro Okamoto, Motoharu Hamatake, Shinkichi Takamori, Mikihiro Kohno, Naoko Miura, Mototsugu Shimokawa, Tomoharu Yoshizumi, null null
Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer? Thoracic cancer (2023)
Yuka Oku, Gouji Toyokawa, Sho Wakasu, Fumihiko Kinoshita, Shinkichi Takamori, Kenji Watanabe, Naoki Haratake, Taichi Nagano, Keisuke Kosai, Kazuki Takada, Airi Fujimoto, Kodo Higashijima, Yoshimasa Shiraishi, Kentaro Tanaka, Hiroaki Takeoka, Masaki Okamoto, Takanori Yamashita, Mototsugu Shimokawa, Fumihiro Shoji, Koji Yamazaki, Tatsuro Okamoto, Takashi Seto, Hitoshi Ueda, Sadanori Takeo, Naoki Nakashima, Isamu Okamoto, Tomoyoshi Takenaka, Tomoharu Yoshizumi
Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients. Cancer medicine (2023)
Taichi Nagano, Shinkichi Takamori, Asato Hashinokuchi, Kyoto Matsydo, Mikihiro Kohno, Naoko Miura, Tomoyoshi Takenaka, Takeshi Kamitani, Mototsugu Shimokawa, Kousei Ishigami, Yoshinao Oda, Tomoharu Yoshizumi
Comparison of radiological and pathological tumor sizes in resected non-small cell lung cancer. General thoracic and cardiovascular surgery (2023)
Shinkichi Takamori, Yasushi Yatabe, Atsushi Osoegawa, Keiju Aokage, Hiroshige Yoshioka, Tomohiro Miyoshi, Takahiro Mimae, Makoto Endo, Aritoshi Hattori, Masaya Yotsukura, Tetsuya Isaka, Mitsuhiro Isaka, Tomohiro Maniwa, Ryu Nakajima, Shun-Ichi Watanabe
Rare but clinically important salivary gland-type tumor of the lung: A review. Japanese journal of clinical oncology (2023)
Taichi Matsubara, Shinkichi Takamori, Takatoshi Fujishita, Ryo Toyozawa, Kensaku Ito, Masafumi Yamaguchi, Takashi Seto, Tatsuro Okamoto
Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy. Thoracic cancer 12 (23) (2021)
Shinkichi Takamori, Mototsugu Shimokawa, Takefumi Komiya
Prognostic impact of chronological age on efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: Real-world data from 86 173 patients. Thoracic cancer 12 (21) (2021)
Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, Shinichiro Shimamatsu, Fumihiko Hirai, Tetsuzo Tagawa, Tatsuro Okamoto, Motoharu Hamatake, Yuko Tsuchiya-Kawano, Kohei Otsubo, Koji Inoue, Yasuto Yoneshima, Kentaro Tanaka, Daisuke Shibahara, Yoichi Nakanishi, Masaki Mori
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting. International journal of cancer 149 (2) (2021)
Shinkichi Takamori, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Ryo Toyozawa, Takashi Seto, Masafumi Yamaguchi, Tatsuro Okamoto
Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation. Thoracic cancer 12 (6) (2021)
Kazuki Takada, Shinkichi Takamori, Naoko Miura, Yasunori Shikada, Mototsugu Shimokawa
Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (35) (2021)
Shinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, Mikako Jinnnouchi, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Mitsuhiro Takenoyama, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, Tetsuzo Tagawa, Masaki Mori
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Cancer immunology, immunotherapy : CII 70 (6) (2021)
Shinkichi Takamori, Nobuki Furubayashi, Kenichi Taguchi, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Masafumi Yamaguchi, Ryo Toyozawa, Takashi Seto, Takahito Negishi, Motonobu Nakamura, Tatsuro Okamoto
Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab. Thoracic cancer 12 (14) (2021)
Shinkichi Takamori, Taro Ohba, Mototsugu Shimokawa, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama
Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study). PloS one 16 (10) (2021)
Shinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Mitsuhiro Takenoyama, Yasuto Yoneshima, Kentaro Tanaka, Daisuke Shibahara, Tetsuzo Tagawa, Masaki Mori
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapy. International journal of cancer 147 (8) (2020)
Kazuki Takada, Shinkichi Takamori, Taichi Matsubara, Naoki Haratake, Takaki Akamine, Fumihiko Kinoshita, Yuki Ono, Sho Wakasu, Kensuke Tanaka, Yuka Oku, Taro Oba, Atsushi Osoegawa, Tetsuzo Tagawa, Mitsuhiro Takenoyama, Mototsugu Shimokawa, Yoshinao Oda, Masaki Mori
Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study. PloS one 15 (11) (2020)
Shinkichi Takamori, Takefumi Komiya, Emily Powell
Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis. Cancer medicine 10 (3) (2020)
Shinkichi Takamori, Takashi Seto, Mikako Jinnouchi, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Mitsuhiro Takenoyama
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancer. Thoracic cancer 11 (7) (2020)
Shinkichi Takamori, Mitsuhiro Takenoyama, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Masafumi Yamaguchi, Ryo Toyozawa, Takashi Seto, Tatsuro Okamoto
Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient. Thoracic cancer 11 (12) (2020)
Shinkichi Takamori, Tetsuzo Tagawa, Gouji Toyokawa, Hiroki Ueo, Mototsugu Shimokawa, Fumihiko Kinoshita, Taichi Matsubara, Yuka Kozuma, Naoki Haratake, Takaki Akamine, Masakazu Katsura, Kazuki Takada, Fumihiko Hirai, Fumihiro Shoji, Tatsuro Okamoto, Yoshinao Oda, Yoshihiko Maehara
The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score-matched analysis. Cancer medicine (2018)